一位中国神经学家在为母亲治疗其他疾病时，使用高强度聚焦超声（FUS）意外改善了她的阿尔茨海默病症状，使其认知功能显著恢复。孙博民医生表示，这是世界上首例有效的阿尔茨海默病FUS治疗。患者已九十多岁，患病约八年，此次治疗于2024年进行。
孙博民医生，一位中国神经学家，在2024年为母亲进行高强度聚焦超声（FUS）治疗时，意外观察到其阿尔茨海默病症状的改善。这位九十多岁的患者此前已患病八年，疾病导致记忆丧失、时间感缺失，并处于被动沉默状态，甚至对亲人去世无反应。
孙博民于1月21日在中国平台Yitiao.tv发布短视频和文章，详细描述了这一过程。他表示，治疗原本针对其他疾病，但母亲的认知突然被激发：她开始认出家人，进行计算、适当回应，并表达情感需求。孙博民提到，她甚至能从100倒数减7，这是一种标准的阿尔茨海默病评估工具。
这一事件发生在浙江省杭州市，孙博民隶属于上海瑞金医院和复旦大学。关键词包括王桂芳、MRI和世界立体定向功能神经外科学会。尽管这被描述为世界首例有效治疗，但需进一步验证其广泛适用性。孙博民的发现为阿尔茨海默病治疗带来新希望，但目前仍基于单一病例。
由 AI 报道 AI 生成的图像 事实核查
Researchers affiliated with MIT argue that transcranial focused ultrasound—a noninvasive technique that can modulate activity in deep brain regions—could enable more direct, cause-and-effect tests of how conscious experiences arise. In a “roadmap” review in *Neuroscience & Biobehavioral Reviews*, they describe experimental approaches aimed at distinguishing between competing accounts of where and how awareness is generated in the brain.
Researchers have demonstrated that restoring levels of a key brain energy molecule can reverse advanced Alzheimer's disease in mouse models, repairing damage and restoring cognitive function. The study, published on December 22, challenges the long-held view that the condition is irreversible. Findings from human brain tissue support the approach's potential relevance to patients.
由 AI 报道
Scientists at Northwestern University have identified a toxic subtype of amyloid beta oligomers that triggers early Alzheimer's changes in the brain. Their experimental drug, NU-9, reduced this damage and inflammation in pre-symptomatic mice, suggesting potential for preventing the disease before symptoms appear. The findings highlight a new strategy for early intervention.
Rice University scientists say they have created the first complete, label-free molecular atlas of an Alzheimer’s brain in an animal model, combining hyperspectral Raman imaging with machine learning to map chemical changes that appear unevenly across brain regions and extend beyond amyloid plaques.
由 AI 报道
A 20-year randomized controlled trial has shown that cognitive speed training, combined with booster sessions, reduces the risk of dementia diagnosis by 25 percent among older adults. The study, involving over 2,800 participants aged 65 and older, focused on a computer-based task requiring quick recall of visual details. While results are promising, experts urge caution due to the study's multiple outcome measures.
A small randomized, double-blind trial suggests that MRI-based measures of brain structure may help predict which patients with major depressive disorder will show early symptom improvement after treatment with the traditional Chinese medicine Yueju Pill. In the four-day study, Yueju Pill and escitalopram were both associated with lower depression rating scores, but only Yueju Pill was linked to a rise in blood levels of brain-derived neurotrophic factor (BDNF).
由 AI 报道
European scientists have developed a preliminary method to identify Alzheimer's using a drop of dried blood from a finger, achieving 86% accuracy in detecting amyloid pathology. The study, validated in 337 patients from several countries, is published in Nature Medicine and aims to simplify early diagnosis of this disease affecting over 50 million people worldwide.